Importance of immunogenicity testing for cost-effective management of psoriasis patients treated with adalimumab

URN:NBN:SI:doc-LNPPALOL2017Mota, FernandoNeves, EsmeraldaOliveira, José CarlosSelores, ManuelaTorres, Tiagodocuments/doc/L/URN_NBN_SI_doc-LNPPALOL_001.pdfdocuments/doc/L/URN_NBN_SI_doc-LNPPALOL_001.txt226articlestr. 33-351318-4458296241664URN:NBN:SI:doc-LNPPALOLengSlovene Welding SocietyActa dermatovenerologica Alpina, Pannonica et AdriaticaInCadalimumabimunogenostluskavicatherapyzdravljenjeImportance of immunogenicity testing for cost-effective management of psoriasis patients treated with adalimumab